Laluna, Jinky M.

HRN: 28-74-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2026
CO-AMOXICLAV 625MG (TAB)
04/26/2026
05/03/2026
PO
1 Tab
Q8
SP NSD In-transit Delivery
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: